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In 1971 the IARC began a programme to publish a series of monographs on compounds for which there was some suggestion of possible carcinogenicity for man. The data are selected and evaluated by working groups of about 12 experts. The result has been an exceptionally useful authoritative series, with a good clear layout, describing chemical properties, production and use, occurrence, analysis and relevant biological data of possibly hazardous compounds.
Volume 13 continues the good job of bringing together the previously scattered data, and of giving a critical appraisal of experiments, on the basis of numbers of animals, duration etc. In many cases there are insufficient data for an evaluation of carcinogenicity, and the working group obviously has a difficult task. Nevertheless, the title of the series leads one to expect some attempt at evaluation of the risk to man. The IARC state that "at the present time no attempt can be made to interpret the animal data directly in terms of human risk". However, there are those, including some members of the working group, who think that an attempt at a tentative evaluation of the relative degrees of risk could be made. For example, it is generally agreed that induction of liver-cell cancer in rats is more cause for concern than induction of hepatomas in mice. In practice, people with varying degrees of understanding of the subject are compelled to make decisions concerning exposure at the present time, before adequate data are available for firm evaluation of risks. The opinions of the working group of experts, in these situations, would be very valuable.
Possibly the most widely used of the drugs included in Volume 13 are phenacetin, phenobarbital and phenylbutazone. It is astonishing that no data are available from carcinogenicity studies in animals for a drug as widely used as is phenylbutazone. Also, the fact that the drug has 129 different names is possibly not an ideal situation. Several compounds considered in Volume 13 are carcinogenic for animals, but there is no firm evidence that any of them, with the exceptions of phenacetin and phenytoin, are carcinogenic for man under the conditions used. Given the data, such as they are, the reader is left to make his own evaluations.
V The contributors to the symposium are all well known workers in the field of paediatric oncology.
All the contributions are w%ell written and contain some useful information. I was particularly pleased to read the paper drawing attention to the importance of studying the later effects of treatment on the developing child and of devising ways to manage these effects, now that more and more children are being cured of their malignancy. Equally important was the multidisciplinary approach and the need for hiigh standards of service, both for diagnosis and management.
The two contributions on genetic, familial and environmental causes and the relationship of cancer to immunological changes, summarise our present knowledge.
There are several papers on the management of lymphomas and leukaemias, with a particularly monumental one on the radiotherapy of the lymphomas. Taken together they give good indications of the uses of chemiotherapy, radiotherapy and immunotherapy in these conditions.
The remaining papers deal mainly with some of the solid tumours. Those on Ewing's rhabdomyosarcoma and Wilms' tumour describe the present situation in terms of the management of these tumours, but the last two deal with results rather vaguely. The papers on neuroblastoma and retinoblastoma on the other hand, successfully cover our knowledge and management of these two interesting tumours.
This was obviously an interesting sym- This book is one of a series of reports produced by WHO Expert Committees. The members are eminent chemotherapists chosen from around the world; the excellence of their knowledge is reflected in both the comprehensiveness and relatively up-to-date content. However, the reviewer questions the value of such books and wonders to which readers it is directed. The volume is not large enough to be a text book on chemotherapy.
It is perhaps to be regarded as an introduction to chemotherapy for those who are not practising it. There appears to have been a regrettable lack of radiotherapeutic advice in the preparation of this document, resulting in one or two lapses in the text, as in discussing Methotrexate and Razoxane as radiosensitisers.
The report is well written. This part of Tumours of the Rat includes chapters on the respiratory tract, liver, urogenital system, pituitary, thyroid, adrenal, central and peripheral nervous systems and the heart. As with Part 1, the aim is to establish a standardized terminology in the field of tumours in laboratory rats. This volume will go some way towards this, but there are obvious differences in nomenclature depending on the source of material. In most chapters there is a brief description of the normal structure of the organ. As a result of their brevity these are of limited use, and in some instances omit important features or may be misleading. On nomenclature, these volumes are internally inconsistent. For example, a "benign hepatoma" is described in the liver, while in the 1968 IARC publication No. 1 on Liver Cancer there was a recommendation that this term should not be used. In the present volume it is being used to designate a "benign neoplasm" while there is an editor's note that the term "hepatoma" in the volume on tumours of the mouse is used for both benign and malignant liver tumours. This is just one example of inconsistency. Many of the chapters give excellent descriptions and illustrations of the tumours, but others are less helpful due to the brevity of the description, as in the nervous system, or in the highly specialized nature of the information, as in the pituitary. For a volume such as this to be successful it is important that the quality of illustration is high. There has been considerable improvement over Part 1, but much remains to be done. For example, in the chapter on tumours of the vagina the selected photographs are often too small to be of use, and following the excellent discussion of the thyroid, many of the illustrations are of poor focus. A good feature of this volume in general is that the authors discuss the problems of differential diagnosis and in particular often refer to the problems in distinguishing hyperplasias from neoplasias. This book can be recommended as a most useful addition to the information which is available on the tumours of laboratory animals.
W This is an excellent publication, dealing with a subject that is currently occupying the minds of very many clinical oncologists.
Chemotherapy has passed through several phases, notably those of the single agent and, later, of the proliferation of ever more exotic combinations for the treatment of advanced malignancy. Adjuvant chemotherapy is the phase of the moment. It is likely (though even this is being questioned) that chemotherapy is most effective when there is a small body-burden of tumour (i.e. micrometastases) so it is very reasonable to offer adjuvant treatment to high-risk patients in this category. This book contains many papers often of a very high standard, dealing with clinical applications and results, but also
